This is the authors' abstract. We don't add key points for this paper.
// Shenglong Zhu 1, 2, 3 , Guangxiao Lin 1, 2 , Ci Song 1, 2 , Yikuan Wu 1, 2 , Ninghan Feng 3, 7 , Wei Chen 1, 2, 4, 5 , Zhao He 1, 2, 3 and Yong Q. Chen 1, 2, 3, 4, 6 1 State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, China 2 School of Food Science and Technology, Jiangnan University, Wuxi, China 3 Wuxi Medical School, Jiangnan University, Wuxi, China 4 National Engineer Research Center for Functional Food, Jiangnan University, Wuxi, China 5 Beijing Innovation Center of Food Nutrition and Human Health, Beijing Technology and Business University, Beijing, China 6 School of Medicine, Wake Forest University, Winston-Salem, North Carolina, USA 7 Wuxi No. 2 Hospital, Jiangsu, P. R. China Correspondence to: Zhao He, email: zhaohe@jiangnan.edu.cn Yong Q. Chen, email: yqchen@jiangnan.edu.cn Keywords: retinoic acid; ω-3 PUFAs; autophagy; breast cancer Received: April 26, 2017 Accepted: September 21, 2017 Published: November 22, 2017 ABSTRACT Retinoic acid (RA), is a promising therapeutic agent for the treatment of breast cancer. However, metabolic disorders and drug resistance reduce the efficacy of RA. In this study, we found that RA and ω-3 polyunsaturated fatty acids (ω-3 PUFAs) synergistically induced cell death in vitro and in vivo and autophagy activation. Moreover, RA-induced hypercholesterolemia was completely corrected by ω-3 PUFA supplementation. In addition, we demonstrated that the effects of this combination on the autophagic flux were independent of the two major canonic regulatory complexes controlling autophagic vesicle formation. The treatment activated Gαq-p38 MAPK signaling pathways, which resulted in autophagy of breast cancer cells. Knockdown of Gαq or P38 expression prevented RA and ω-3 PUFAs from inducing autophagy. Data indicated that Gαq-p38activation was mediated by the co-activation of GPR40 and RARα in lipid rafts, rather than by the activation of GPR120, RARβ, or RARγ. The results of this study suggest that hyperlipidemic drug side effects may be ameliorated by the administration of ω-3 PUFAs. Thus, the therapeutic indexes of the corresponding drugs may be increased.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: